Company intelligence / Profile preview

TURBO Labs

Shilin District, Taipei City, Taiwanturbolabs.io ↗

Ownership: Private
Development stage: Commercial

Overview

LabTurbo’s automated molecular diagnostic systems are commercially available and used globally. Their solutions enable rapid, high-sensitivity detection of genetic markers for cancer, infectious disease pathogens, and hereditary conditions. The company holds CAP certification for its clinical lab operations in the US.

Therapeutic areas: OncologyRare DiseasesInfectious Diseases
Modalities: Diagnostic deviceMultiplex PCR panelNucleic acid extraction technology
Industry: Molecular Diagnostics

Partnerships

Collaborates with CRO companies to support clinical trials as a CLIA-certified lab

Beyond the preview

Go deeper on TURBO Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TURBO Labs.

Explore the full profile